By Eliza Mcphee For Daily Mail Australia
Published: 04:23 BST, 4 May 2021 | Updated: 04:23 BST, 4 May 2021
An Australian biotech company has joined the fight against coronavirus by launching an anti-viral nasal spray that's already available in the UK.
Starpharma first rolled out the product known as Viraleze in London at the end of March and it's currently being sold for the equivalent of A$27 in Lloyds Pharmacy chemists across the city.Insurance Loans Mortgage Attorney Credit Lawyer
The spray, which was developed in Melbourne, works by 'deactivating' the virus as soon as it enters the nose, preventing the person using it from getting sick.
CEO of the company, Jackie Fairley, said the spray is best used once every six hours for up to 30 days - acting as a form of defence to the virus when social distancing is not possible.
While the product is not yet available within Australia, the company says it has plans to launch the spray on home soil soon.
Melbourne-based company, Starpharma, first rolled out the product known as Viraleze in London at the end of March
'Viraleze is actually all about trying to stop it and kill it before entering your body,' she told
'If you're using it when going on a train or in the supermarket then you might use it just as needed.'
The spray targets the area in the nose where respiratory viruses like colds and flus first become active, the company's website explains.
'The nasal cavity